20 November 2009



("Sareum or the "Company)

Availability of Report & Accounts


The Company announces that the report and accounts for the year ended 30 June 2009 has now been posted to shareholders and is available from the Company’s website www.sareum.co.uk.


Sareum Holdings plc


Tim Mitchell

01223 497 700



Merchant John East Securities Limited (Nominated Adviser)

Simon Clements/Bidhi Bhoma

020 7628 2200



Hybridan LLP (Broker)


Claire Noyce/Stephen Austin

020 3159 5085

Notes for editors:

About Sareum Holdings plc 

Sareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.

Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.

Sareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR.  For further information, please visit www.sareum.co.uk